ATE255407T1 - Pharmazeutische zusammensetzungen, die terbinafin enthalten - Google Patents

Pharmazeutische zusammensetzungen, die terbinafin enthalten

Info

Publication number
ATE255407T1
ATE255407T1 AT01925320T AT01925320T ATE255407T1 AT E255407 T1 ATE255407 T1 AT E255407T1 AT 01925320 T AT01925320 T AT 01925320T AT 01925320 T AT01925320 T AT 01925320T AT E255407 T1 ATE255407 T1 AT E255407T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
terbinafin
containing terbinafin
composition
Prior art date
Application number
AT01925320T
Other languages
English (en)
Inventor
Jean-Daniel Bonny
Andreas Carl Eugster
Patrice Guitard
Stefan Hirsch
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE255407T1 publication Critical patent/ATE255407T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01925320T 2000-01-27 2001-01-25 Pharmazeutische zusammensetzungen, die terbinafin enthalten ATE255407T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0001928.1A GB0001928D0 (en) 2000-01-27 2000-01-27 Organic compounds
PCT/EP2001/000834 WO2001054675A2 (en) 2000-01-27 2001-01-25 Pharmaceutical compositions comprising terbinafine

Publications (1)

Publication Number Publication Date
ATE255407T1 true ATE255407T1 (de) 2003-12-15

Family

ID=9884486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925320T ATE255407T1 (de) 2000-01-27 2001-01-25 Pharmazeutische zusammensetzungen, die terbinafin enthalten

Country Status (12)

Country Link
US (4) US20090143479A1 (de)
EP (1) EP1250125B1 (de)
JP (1) JP5036114B2 (de)
AT (1) ATE255407T1 (de)
AU (1) AU5211901A (de)
DE (1) DE60101370T2 (de)
DK (1) DK1250125T3 (de)
ES (1) ES2211797T3 (de)
GB (1) GB0001928D0 (de)
PT (1) PT1250125E (de)
TR (1) TR200400314T4 (de)
WO (1) WO2001054675A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60231549D1 (de) * 2001-12-03 2009-04-23 Dor Biopharma Inc Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
JP2005104924A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 外用医薬組成物
FR2861992B1 (fr) * 2003-11-10 2007-07-20 Sanofi Synthelabo Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
CN101467960B (zh) * 2007-12-29 2012-11-28 浙江康恩贝制药股份有限公司 一种盐酸特比萘芬乳膏及其制备方法
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
KR101623928B1 (ko) * 2015-02-24 2016-05-24 한양대학교 에리카산학협력단 자가나노유화 약물 전달시스템을 이용한 에제티미브의 경구용 고형제제 조성물
US12594260B2 (en) * 2024-06-28 2026-04-07 Topical Rx, LLC Topical formulations for infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3694557A (en) * 1970-10-23 1972-09-26 Amazon Natural Drug Co The Anti-inflammation compositions containing taspine or acid salts thereof and method of use
JPS5913717A (ja) * 1982-07-16 1984-01-24 Asahi Chem Ind Co Ltd エマルジヨン製剤
EP0295865B1 (de) * 1987-06-15 1994-01-26 Sbp, Inc. Esswaren enthaltend Parenchymzellen-Zellulose
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
JPH10338613A (ja) * 1997-06-06 1998-12-22 Pola Chem Ind Inc 透明化粧料
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
CN1208047C (zh) * 1997-07-29 2005-06-29 法玛西雅厄普约翰美国公司 亲脂性化合物的自体乳化剂
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions

Also Published As

Publication number Publication date
JP5036114B2 (ja) 2012-09-26
EP1250125A2 (de) 2002-10-23
AU5211901A (en) 2001-08-07
ES2211797T3 (es) 2004-07-16
WO2001054675A2 (en) 2001-08-02
DE60101370T2 (de) 2004-10-28
US20090143479A1 (en) 2009-06-04
EP1250125B1 (de) 2003-12-03
US20110086071A1 (en) 2011-04-14
US20130236514A1 (en) 2013-09-12
TR200400314T4 (tr) 2004-03-22
DE60101370D1 (de) 2004-01-15
JP2003521495A (ja) 2003-07-15
DK1250125T3 (da) 2004-03-29
GB0001928D0 (en) 2000-03-22
PT1250125E (pt) 2004-04-30
US20120244194A1 (en) 2012-09-27
WO2001054675A3 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
DE60104206D1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
SE0301700D0 (sv) Novel compounds
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
HUP0203176A2 (hu) Szimetikont tartalmazó orális, szilárd adagolási forma
CY1107512T1 (el) Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
UY28348A1 (es) Compuestos novedosos
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
HN2001000262A (es) Kit de repinotano
HRP20070476T3 (en) Treatment of dependence withdrawal
DE60101370D1 (de) Pharmazeutische zusammensetzungen, die terbinafin enthalten
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
MXPA03003795A (es) Formulaciones autoemulsionantes de dosis orales de inhibidores de proteasa de tipo piranona.
BRPI0408848A (pt) formulações orais de cladribine
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
MA27921A1 (fr) Systemes emulsifiants contenant des derives d'azetidine
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
SE0001916D0 (sv) Novel formulation
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
MXPA01011842A (es) Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
DZ3103A1 (fr) Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation.
CY1106964T1 (el) Φαρμακα που περιεχουν ν,ν’-διυποκατεστημενες ενωσεις πιπεραζινης και η χρησιμοποιηση τους

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1250125

Country of ref document: EP